ArticlePsychopharmacology2026
17β-Estradiol alleviates cognitive deficits by modulating fear memory reconsolidation in a PTSD rat model.
Article in Psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
rationaleImpaired fear memory extinction is a core symptom of post-traumatic stress disorder (PTSD). Alleviating pathological fear memory is crucial for treating PTSD and related fear disorders.
objectives17β-estradiol (17β-E2) critically regulates hippocampal learning and memory. This study explored effects of gonadal and hippocampal 17β-E2 on cognitive function during fear memory reconsolidation in a rat PTSD model.
methodsIn female rats, ovariectomy with intraperitoneal 17β-E2 injection manipulated gonadal hormone levels, while intracerebral letrozole regulated hippocampal 17β-E2 synthesis.
resultsSPS-CFC model rats showed enhanced fear responses and anxiety-depression-like behaviors during fear memory reconsolidation. Elevated 17β-E2 ameliorated these PTSD-like phenotypes. Hippocampal mRNA and protein levels of PSD‑95, ERK1/2, p‑ERK1/2, and BDNF were upregulated, and synaptic structure improved.
conclusionsThese findings demonstrate that both gonadal-derived and hippocampus-derived 17β-E2 relieve cognitive deficits and emotional disorders during fear memory reconsolidation in PTSD model rats, providing a potential target for PTSD intervention.
Indexed as
Identifiers
42032154What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.